Though select studies have affirmed the positive association between PD-L1 expression and increased lymphocyte infiltration in IBC, some suggest that PD-L1 expression is associated with an apparent anti-tumor CD8+ T-cell response [33,70]. The gene discussed is CD8A; the disease is inflammatory breast carcinoma.